First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
Year: 2015
Type: article
Study design: Clinical Trial
Source: JAMA Oncology
Authors: Keunchil Park, Chong-Jen Yu, Sang-We Kim, Meng-Chih Lin, Virote Sriuranpong, Chun-Ming Tsai, Jong-Seok Lee, Jin-Hyoung Kang, K. C. Allen Chan, Pablo Perez-Moreno, Peter Button, Myung-Ju Ahn, Tony Mok
Institutions: Samsung Medical Center, Sungkyunkwan University, National Taiwan University Hospital, Asan Medical Center, University of Ulsan, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Chulalongkorn University, Taipei Veterans General Hospital, National Yang Ming University, Seoul National University Bundang Hospital, The Catholic University of Korea Seoul St. Mary's Hospital, Chinese University of Hong Kong, F. Hoffmann-La Roche AG
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2218718059